Article Title,Year,Volume,Issue,Page Range,Author
Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse,2006,21,2,111-115,Fazel
Do antidepressants prevent suicide?,2006,21,4,211-218,Kvist
Association between antidepressant prescribing and suicide in Israel,2006,21,5,281-284,Barak
Suicide in adolescents,2001,16,Suppl 2,S1-S6,van Heeringen
Suicide in population subgroups,2001,16,Suppl 2,2p preceding S1,Sartorius
Antidepressants: the implications of the cognitive and psychomotor effects in the elderly,1990,5,Suppl 3,57-60,Hindmarch
The effect of zopiclone 7.5 mg on the sleep mood and performance of shift workers,1990,5,Suppl 2,79-83,Hindmarch
The risk of suicide with antidepressants,1988,3,Suppl 2,15-24,Lambert
The mortality associated with depression,1988,3,Suppl 2,1-13,Sims
The value of low speed off-road driving tasks,1988,3,Suppl 1,87-98,Betts
Are actual driving tests necessary for evaluating drug safety?,1988,3,Suppl 1,81-85,O'Hanlon
A proposed investigation into drug impairment testing methodology,1988,3,Suppl 1,99-109,Irving
The psychopharmacological approach: effects of psychotropic drugs on car handling,1988,3,Suppl 1,73-79,Hindmarch
A co-ordinated approach to the drugs and traffic safety problem,1988,3,Suppl 1,35-53,Starmer
Epidemiological methods in causal accident research,1988,3,Suppl 1,23-33,Honkanen
General practitioner prescribing for the driving patient,1988,3,Suppl 1,147-153,Beaumont
Information for the driver,1988,3,Suppl 1,145-146,Carr
Driving and drug regulation,1988,3,Suppl 1,141-143,Isaacs
Road traffic safety and the pharmaceutical industry,1988,3,Suppl 1,133-140,Stonier
The international (mainly European) attitude to the drug driving problem--legislation and countermeasures,1988,3,Suppl 1,13-21,Irving
The drugs (medicines) driving situation in the UK,1988,3,Suppl 1,1-12,Sabey
The influence of psychiatric disease and its treatment on driving performance,1988,3,Suppl 1,59-66,Silverstone
The influence of physical disease and its treatment on driving performance,1988,3,Suppl 1,55-57,Taylor
Sleepiness and motor vehicle accidents,1988,3,Suppl 1,111-116,Roth
The significance of impaired performance,1988,3,Suppl 1,117-127,Nicholson
Methaqualone,1988,3,2,97-109,Ionescu-Pioggia
An investigation of the effects of lofepramine nomifensine amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving,1988,3,2,157-165,Harrison
Lithium for the control of aggressive and self-mutilating behaviour,1987,2,3,181-190,Wickham
Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological control,1986,1,Suppl 1,63-74,Read
Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients,1997,12,3,159-169,Ramaekers
The behavioural toxicity of the selective serotonin reuptake inhibitors,1995,9,Suppl 4,13-17,Hindmarch
The importance of accidents in evaluating the cost of SSRIs: a review,1994,9,3,195-201,Hale
Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder,2009,24,1,26-28,Phillips
Placebo-controlled randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers,2008,23,6,337-341,Coccaro
Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment,2007,22,5,249-267,Meltzer
Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women,2006,21,5,275-280,Petty
Psychomotor effects of astemizole and chlorpheniramine alone and in combination with alcohol,1987,2,2,117-119,Hindmarch
Psychotropic drugs in suicidal patients: a comparison of psychotropic medications in attempters and completed suicides,1990,5,4,291-294,Youssef
5-HT reuptake inhibitors tricyclic antidepressants and suicidal behaviour,1991,6,Suppl 3,49-55; discussion 55-6,Bullock
Biological studies and markers in suicide and attempted suicide,1991,6,2,77-92,Stanley
Does treatment with antidepressant medication increase suicidal behavior?,1991,6,4,219-226,Goldblatt
Serotonin and psychiatric disorders,1992,7,Suppl 2,5-11,López-Ibor
The provocation and prevention of suicide attempts,1992,6,Suppl 6,28-34,Bullock
Toxicity of antidepressants: comparisons with fluoxetine,1992,6,Suppl 6,22-27,Henry
Epidemiology of suicide,1992,6,Suppl 6,1-11,Farmer
Suicide risk and serotonin,1992,6,Suppl 6,12-21,Åsberg
Self- and other-directed human aggression: the role of the central serotonergic system,1992,6,Suppl 6,70-83,Coccaro
Attempted suicide: efficacy of different aftercare strategies,1992,6,Suppl 6,58-69,Moller
Suicide prevention and serotonergic drugs,1993,8,Suppl 2,83-85,Montgomery
The serotonin system and aggressive personality disorder,1993,8,Suppl 2,33-39,Siever
Fluoxetine not associated with increased aggression in controlled clinical trials,1993,8,4,277-280,Beasley
The morbidity and mortality of clinical depression,1993,8,4,217-220,Fawcett
Comorbidity of anxiety phobia compulsion and depression,1993,8,Suppl 1,21-25,Angst
Impulse control disorders,1993,8,Suppl 1,53-56,George
Medicines and road traffic safety,1988,3,Suppl 1,1-158,
The costs of depression,1993,7,3-4,191-195,Sorensen
Effects of fluoxetine on psychomotor performance cognitive function and sleep in depressed patients,1993,8,4,341-343,Hindmarch
How to improve the risk-benefit ratio of antidepressants,1993,8,4,237-241,Corruble
Current concepts of the classification of affective disorders,1993,8,4,211-215,Angst
Reducing the economic burden of depression,1994,9,4,229-243,Lane
Violent trauma among child and adolescent girls: current knowledge and implications for clinicians,2000,15,Suppl 3,S51-9,Stein
Diagnostic anomalies in social phobia,1996,11,Suppl 3,29-33,Tyrer
The cross-national epidemiology of social phobia: a preliminary report,1996,11,Suppl 3,9-14,Weissman
First report of mirtazapine overdose,1996,11,2,147,Hoes
Risk of suicide in depression and its implication for psychopharmacological treatment,1996,11,2,71-79,Kasper
Depressive disorders and other emotional issues in the elderly: current issues,1997,12,Suppl 7,S37-42,Salzman
Evidence for the efficacy of duloxetine in treating mild moderate and severe depression,2007,22,6,348-355,Raskin
A randomized double-blind placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life,2007,22,1,29-37,Endicott
Affective psychosis following Accutane (isotretinoin) treatment,2005,20,1,39-41,Knobler
Suicide in women,2001,16,Suppl 2,S7-19,Brockington
Panic and depression: a worldwide primary care perspective,1998,13,Suppl 4,S7-11,Üstün
Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine,1993,8,2,115-118,Rimón
Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder,1995,10,3,177-179,Coccaro
Sertraline 50 mg daily: the optimal dose in the treatment of depression,1995,10,3,129-141,Preskorn
5-HT-related anxiety- and/or aggression-driven depression,1994,9,Suppl 1,5-6,van Praag
A review of the psychomotor effects of paroxetine,1997,12,1,13-18,Hawley
Effects of mizolastine a new antihistamine on psychomotor performance and memory in elderly subjects,1994,9,2,101-108,Rosenzweig
Aripiprazole and suicidality,2006,21,2,125-126,Holzer
Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials,2005,20,5,275-283,LeBlanc
Effects of clorazepate diazepam and oxazepam on a laboratory measurement of aggression in men,1998,13,4,183-188,Berman
Serotonergic function after (+/-)34-methylene-dioxymethamphetamine ('Ecstasy') in humans,1998,13,1,1-9,Gerra
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility,2007,22,6,356-362,Czobor
Violence against women: an emerging health problem,2000,15,Suppl 3,S37-45,Jewkes
Psychiatric aspects of women's health,2000,15,Suppl 3,S1-4,Stein
The effects of codeine on human aggressive responding,1990,5,3,195-204,Spiga
Neurobiology of obsessive compulsive disorder: a review,1992,7,Suppl 1,31-33,Insel
Somnambulistic-like behaviour in patients attending a lithium clinic,1999,14,3,173-175,Montplaisir
Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice,1999,14,3,167-171,Ponds
Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department,1999,14,6,361-372,Battaglia
Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship,1992,7,1,3-12,Coccaro
A comparison of the efficacy safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia,1990,5,Suppl 2,29-37,McClure
Actions and interactions of hypnotics on human performance: single doses of zopiclone triazolam and alcohol,1990,5,Suppl 2,115-130,Kuitunen
Immediate and overnight effects of zopiclone 7.5 mg and nitrazepam 5 mg with ethanol on psychomotor performance and memory in healthy volunteers,1990,5,Suppl 2,105-113,Hindmarch
Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes,1993,8,4,281-293,Tollefson
Clinical implications of the pharmacology of sertraline,1991,6,Suppl 2,11-21,Warrington
Lithium in drinking water and suicide prevention: a review of the evidence,2014,30,1,1-5,Vita
Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study,2014,30,1,49-53,Danel
Interactions of alcohol with amitriptyline fluoxetine and placebo in normal subjects,1989,4 Suppl 1,,7-14,Allen
Study on performance and alcohol interaction with the antidepressant fluoxetine,1989,4 Suppl 1,,15-20,Schaffler
Effects of dihydroergotamine on psychomotor function neuroendocrine parameters and blood pressure in healthy volunteers,1989,4,1,71-83,Puech
The specificity of the zimelidine reaction,1989,4,1,19-23,James
Serotoninergic effects on sensory and motor responses in extraverts and introverts,1989,4 Suppl 1,,21-26,Netter
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - a European multicentre study,2015,31,1,1-7,Serretti
Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized double-blind placebo-controlled trials,2017,32,5,281-288,Thase
Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders,2018,33,3,140-146,Dell'osso
The association between gabapentin and suicidality in bipolar patients,2019,34,1,27-32,Freeman
Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder,2019,34,2,76-83,Vieta
Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report,2021,36,6,296-304,Demler
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder,2021,ePub,ePub,ePub,Serretti
Suicidality in a psychiatric inpatient unit: a 2-year retrospective study in Umbria central Italy,2023,ePub,ePub,ePub,Moretti
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations,2023,ePub,ePub,ePub,Pompili
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study,2023,38,2,73-80,Fadaei
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland,2022,ePub,ePub,ePub,Hakko
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder,2023,ePub,ePub,ePub,Serretti
In search of clinical targets for suicide prevention in major depressive disorder,2023,ePub,ePub,ePub,Serretti
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates,2023,ePub,ePub,ePub,Ploderl
Antidepressant emergent mood switch in major depressive disorder: onset clinical correlates and impact on suicidality,2023,ePub,ePub,ePub,Serretti
Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis,2023,ePub,ePub,ePub,Jiménez-Garrido
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors,2022,37,5,193-200,Serretti
Risk of VMAT2 inhibitors on suicidality and Parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system,2024,ePub,ePub,ePub,McIntyre
Differences in depressive symptoms between Korean and American outpatients with major depressive disorder,2014,29,3,150-156,Clain
Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: A randomized open-label parallel-group flexible-dose study,2014,29,3,166-176,Di Fiorino
Suicidality and psychotic episodes after starting aripiprazole: two case reports,2022,37,5,225-228,Javelot
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding,2022,37,6,279-280,Pompili
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study,2021,36,6,288-295,Gündoğmuş
Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression,1992,6,,35-57,Sayler
Paroxetine: an overview of dosage tolerability and safety,1992,6 Suppl 4,,69-80,Jenner
The advantages of paroxetine in different subgroups of depression,1992,6 Suppl 4,,91-100,Montgomery
The acute and long-term treatment of major depression,1992,7 Suppl 2,,21-29,Mendels
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine,1995,9 Suppl 4,,3-12,Montgomery
Prophylactic potential of selective reuptake inhibitors in suicidal patients,1995,9 Suppl 4,,61-65,Banki
Does selectivity matter?,1996,11 Suppl 1,,13-17,Deakin
Early detection and intervention in schizophrenia,1998,13 Suppl 3,,S31-34,Goldstein
Non-fatal mirtazapine overdose,1998,13,6,277-279,Rösler
The epidemiology of affective disorders in the elderly: a review,1997,12 Suppl 7,,S3-13,Skoog
Topiramate as a mood stabilizer,2001,16,5,295-298,Kasper
Atypical antipsychotics in mood disorders,2002,17 Suppl 3,,S1-10,Letmaier
A double-blind randomized parallel-group flexible-dose study to evaluate the tolerability efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder,2006,21,3,159-169,Baldwin
Predictors of clozapine discontinuation in patients with schizophrenia,2011,26,6,311-315,Weizman
Diagnostic issues in depression in old age,1990,5,Suppl 3,1-6,Wattis
5-HT reuptake inhibitors tricyclic antidepressants and suicidal behaviour,1991,6,Suppl 3,49-56,Montgomery
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition,2024,ePub,ePub,ePub,Torrente
Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series,2024,39,4,284-287,Pompili